Work

Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights

Year: 2017

Type: editorial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.75.4242

Authors: Grant D. Stewart, Bradley C. Leibovich, Sylvie Negrier, Robert A. Figlin

Institutions: Cedars-Sinai Medical Center, Mayo Clinic, University of Cambridge

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2766391336

Cites: 10

Cited by: 2

Related to: 10